GB:0UGB Stock Latest News
Company AnnouncementsCOSCIENS Biopharma Details Financing Push as It Integrates Nualtis Acquisition2w ago
Company AnnouncementsCOSCIENS Biopharma Expands Convertible Debenture Financing With Second Tranche1M ago
Company AnnouncementsCOSCIENS Biopharma Swings to First-Half Profit and Cuts Costs as It Exits SEC Reporting2M ago
Company AnnouncementsCOSCIENS Biopharma Restructures Share Capital and Moves to Suspend U.S. Reporting4M ago6K
Company AnnouncementsCOSCIENS Biopharma Sets July 3 Effective Date for Share Capital Overhaul and U.S. Reporting Exit4M ago6K
Company AnnouncementsCOSCIENS Biopharma Shareholders Approve Capital Restructuring as Board Confirms Puccetti as CEO4M ago6KCompany AnnouncementsCOSCIENS Biopharma Calls June 17, 2026 Special and Annual Shareholder Meeting5M ago6K
Company AnnouncementsCOSCIENS Biopharma posts sharp Q1 profit and stronger balance sheet in May 2026 filing5M ago6K
- Company AnnouncementsCOSCIENS Biopharma Posts Q1 Profit as German Units Exit and SEC Reporting Cutback Advances5M ago6K
Company AnnouncementsCOSCIENS Biopharma Sets June 17, 2026 Virtual Annual and Special Shareholder Meeting5M ago6K
Company AnnouncementsCOSCIENS Biopharma Seeks Approval for Share Capital Restructuring and Virtual AGM in June 20266M ago6K
Company AnnouncementsCOSCIENS Biopharma Addresses Unusual Trading Surge Amid Ongoing Risk Pressures6M ago6K
Company AnnouncementsCOSCIENS Biopharma Slashes Losses, Shuts German Units as It Tightens Focus on Core Ingredients7M ago6KCompany AnnouncementsCOSCIENS Biopharma Shuts Off Funding to German Units, Exits Macrilen Business8M ago6K
Company AnnouncementsCOSCIENS Biopharma Sets April 7 Virtual Special Meeting, Outlines Forward-Looking Risks8M ago6K
- Company AnnouncementsCOSCIENS Biopharma Secures Exclusive Distribution Deal for Macrilen® in Asia11M ago6K
- Company AnnouncementsCOSCIENS Biopharma Appoints New Interim CEO Amid Strategic Shifts11M ago6K
- Company AnnouncementsCOSCIENS Biopharma Reports Q3 2025 Financial Results11M ago
- Company AnnouncementsCOSCIENS Biopharma Reports Q3 2025 Results and Strategic Updates11M ago
Company AnnouncementsCOSCIENS Biopharma Reports Q2 2025 Results and Strategic Updates1y agoCSCICompany AnnouncementsCOSCIENS Biopharma Reports Q2 2025 Results and Strategic Delisting from Nasdaq1y agoCSCI
